Journal articles

2022

ref_biblio

Lauriane Delay, Julie Barbier, Youssef Aissouni, Alexandra Jurczak, Ludivine Boudieu, et al.. Tyrosine kinase type A–specific signalling pathways are critical for mechanical allodynia development and bone alterations in a mouse model of rheumatoid arthritis. Pain, 2022, 163 (7), pp.e837-e849. ⟨10.1097/j.pain.0000000000002492⟩. ⟨hal-04316536⟩

Accès au bibtex

2020

ref_biblio

Tanguy Chaumette, Lauriane Delay, Julie Barbier, Ludivine Boudieu, Youssef Aissouni, et al.. c-Jun/p38MAPK/ASIC3 pathways specifically activated by nerve growth factor through TrkA are crucial for mechanical allodynia development. Pain, 2020, pp.1. ⟨10.1097/j.pain.0000000000001808⟩. ⟨hal-02464551⟩

Accès au texte intégral et bibtex

2019

ref_biblio

Ludivine Boudieu, Sarah Mountadem, Amandine Lashermes, Mathieu Meleine, Lauriane Ulmann, et al.. Blocking α2δ-1 Subunit Reduces Bladder Hypersensitivity and Inflammation in a Cystitis Mouse Model by Decreasing NF-kB Pathway Activation. Frontiers in Pharmacology, 2019, 10, pp.133. ⟨10.3389/fphar.2019.00133⟩. ⟨hal-02324745⟩

Accès au texte intégral et bibtex

2018

ref_biblio

Laura Poupon, Sylvain Lamoine, Vanessa Pereira, David Barriere, Stéphane Lolignier, et al.. Targeting the TREK-1 potassium channel via riluzole to eliminate the neuropathic and depressive-like effects of oxaliplatin. Neuropharmacology, 2018, 140, pp.43-61. ⟨10.1016/j.neuropharm.2018.07.026⟩. ⟨hal-02065469⟩

Accès au texte intégral et bibtex

2017

ref_biblio

Laurent Sakka, Nathalie Delétage, Maryse Chalus, Youssef Aissouni, Valérie Sylvain-Vidal, et al.. Assessment of citalopram and escitalopram on neuroblastoma cell lines. Cell toxicity and gene modulation. Oncotarget, 2017, ⟨10.18632/oncotarget.17050⟩. ⟨hal-01682123⟩

Accès au texte intégral et bibtex

2016

ref_biblio

Sylvie Diochot, Abdelkrim Alloui, Précillia Rodrigues, Mélodie Dauvois, Valérie Friend, et al.. Analgesic effects of mambalgin peptide inhibitors of acid-sensing ion channels in inflammatory and neuropathic pain. Pain, 2016, 157 (3), pp.552-559. ⟨10.1097/j.pain.0000000000000397⟩. ⟨hal-02267118⟩

Accès au texte intégral et bibtex

2013

ref_biblio

Bruno Vilar, Jérôme Busserolles, Bing Ling, Sophie Laffray, Lauriane Ulmann, et al.. Alleviating Pain Hypersensitivity through Activation of Type 4 Metabotropic Glutamate Receptor. Journal of Neuroscience, 2013, 33 (48), pp.18951-18965. ⟨10.1523/JNEUROSCI.1221-13.2013⟩. ⟨hal-02448295⟩

Accès au texte intégral et bibtex

2006

ref_biblio

Carine Pestourie, Laura Cerchia, Karine Gombert, Youssef Aissouni, Jocelyne Boulay, et al.. Comparison of different strategies to select aptamers against a transmembrane protein target.. Oligonucleotides, 2006, 16 (4), pp.323-35. ⟨10.1089/oli.2006.16.323⟩. ⟨hal-00168038⟩

Accès au bibtex

Preprints, Working Papers, ...

2021

ref_biblio

Florian Jacquot, Spiro Khoury, Bonnie Labrum, Kevin Delanoe, Ludivine Pidoux, et al.. Lysophosphatidyl-choline 16:0 mediates persistent joint pain through Acid-Sensing Ion Channel 3: preclinical and clinical evidences. 2021. ⟨hal-03187657⟩

Accès au texte intégral et bibtex